$SLRX News Article - Salarius Pharmaceuticals Initiates Expansion Stage of Phase 1/2 Clinical Trial of Seclidemstat in Patients with Ewing Sarcoma and Ewing-Related Sarcomas https://marketwirenews.com/news-releases/sala...91463.html
(0)
(0)
Salarius Pharmaceuticals, Inc. (SLRX) Stock Research Links